Three recent developments are detailed that offer some hope to the nearly 5 million South Africans living with HIV/AIDS: the authority of a South African drug company to develop and produce generic antiretrovirals locally and cheaply via voluntary licensing agreements from larger, global drug companies; the signing of an agreement between South African government and the Global Fund to Fight AIDS, Tuberculosis and Malaria to provide a grant of US$41 million over 2 years for treatment and prevention of HIV/AIDS and tuberculosis; and the publishing of a report of the joint Health and Treasury Task Team on Treatment options to supplement comprehensive care for HIV/AIDS in the public health sector was approved at a special Cabinet meeting last week.
The editorial concludes: 'Many South Africans with HIV/AIDS have waited a long time while being repeatedly disappointed by their government leaders, many have died. South Africans are understandably impatient and sceptical. But now there is a real chance to leave the past behind and move swiftly forward to a better future for the people of South Africa. We urge the government to put the recommendations into practice.'
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.